Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited (CCM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ccm · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Concord Medical Services Holdings Limited (CCM) measures how much investors pay for each dollar of the company's trailing earnings. CCM's current PE ratio of N/A is calculated by dividing its stock price of $4.78 by its TTM earnings per share of -$1102.72.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2008 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 6 fiscal years · Front-end computedMinQ1 · 25%6.6x
MedianQ3 · 75%16.1x
Max
At N/A, CCM's current P/E is lower than in 0% of its annual fiscal year readings over the past 6 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Concord Medical Services Holdings LimitedYou CCM | $1M | N/A | — | -$1102.72 |
 Aditxt, Inc. ADTX | $0M | N/A | — | -$1116.70 |
 IMAC Holdings, Inc. BACK | $0M | N/A | — | -$5.76 |
 Celularity Inc. CELU | $20M | N/A | — | -$3.59 |
 Hepion Pharmaceuticals, Inc. HEPA | $1M | N/A | — | -$0.88 |
 INVO Fertility, Inc. IVF | $2M | N/A | — | -$199.20 |
 Petros Pharmaceuticals, Inc. PTPI | $0M | 1.17x | — | $0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-637.37 | — | |
2024-12-31 FY2024 | — | $-2117.05 | — | |
2023-12-31 FY2023 | — | $-2044.35 | — | |
2022-12-31 FY2022 | — | $-3363.06 | — | |
2021-12-31 FY2021 | — | $-5635.16 | — | |
2020-12-31 FY2020 | — | $-6986.98 | — | |
2019-12-31 FY2019 | — | $-3817.43 | — | |
2018-12-31 FY2018 | — | $-2484.57 | — | |
2017-12-31 FY2017 | — | $-1967.16 | — | |
2016-12-31 FY2016 | — | $-1804.32 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Concord Medical Services Holdings Limited (CCM) measures how much investors pay for each dollar of the company's trailing earnings. CCM's current PE ratio of N/A is calculated by dividing its stock price of $4.78 by its TTM earnings per share of -$1102.72.
Frequently asked questions
CCM pe ratio · 6 questionsCCM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.78 and TTM EPS of -$1102.72. Data sourced from Financial Modeling Prep via CCM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Concord Medical Services Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09